Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Toronto
$105,000.00
Novel Combination Therapies for Peritoneal Carcinomatosis: Chemotherapy and Targeted Radiation to Enhance the Anti-Tumour Efficacy of a Double Deleted Vaccinia Virus
FY 2009-10
Summary
Peritoneal carcinomatosis (dissemination of tumours throughout the peritoneal cavity) is characteristic of late stage colon cancer and is a disease for which there are few safe and effective treatments. The overall objective of this project is to develop novel targeted combination therapies to improve the outcomes of patients with peritoneal carcinomatosis of colonic origin. We will combine an oncolytic vaccinia virus (vvDD), which has shown some efficacy in models of peritoneal carcinomatosis, with chemotherapy or targeted radiation therapy in in vitro and in vivo models of peritoneal carcinomatosis. We hypothesize that combination therapy will result in a synergistic anti-tumour effect leading to significant dose-reductions. The findings of this project are crucial to evaluating the translational potential of these combination therapies and could significantly impact patients with treatment refractory peritoneal carcinomatosis.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
206187
Name
Ottolino-Perry Kathryn M
Region
Ontario
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Novel Combination Therapies for Peritoneal Carcinomatosis: Chemotherapy and Targeted Radiation to Enhance the Anti-Tumour Efficacy of a Double Deleted Vaccinia Virus
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Cancer Therapy; Chemotherapy; In Vitro Tumor Models; In Vivo Fluorescence Imaging; In Vivo Tumour Models; Molecular Imaging; Oncolytic Viruses; Peritoneal Carcinomatosis; Targeted Radiotherapy; Vaccinia Virus
Abstract
Peritoneal carcinomatosis (dissemination of tumours throughout the peritoneal cavity) is characteristic of late stage colon cancer and is a disease for which there are few safe and effective treatments. The overall objective of this project is to develop novel targeted combination therapies to improve the outcomes of patients with peritoneal carcinomatosis of colonic origin. We will combine an oncolytic vaccinia virus (vvDD), which has shown some efficacy in models of peritoneal carcinomatosis, with chemotherapy or targeted radiation therapy in in vitro and in vivo models of peritoneal carcinomatosis. We hypothesize that combination therapy will result in a synergistic anti-tumour effect leading to significant dose-reductions. The findings of this project are crucial to evaluating the translational potential of these combination therapies and could significantly impact patients with treatment refractory peritoneal carcinomatosis.
Competitiondate
200910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ottolino-Perry, Kathryn M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~